Vaccine administration is shifting from multidose vials to prefilled syringes for a host of important safety and economic considerations
Janice Adkins, Brian Lynch
Advertisement
Articles by Janice Adkins, Brian Lynch
Advertisement
Latest Updated Articles
- A growing preference for ready-to-administer vaccines: new guidelines, evidence, and trends
Published: August 27th 2013 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Cambrex Commits $120 Million to Grow US API Manufacturing
2
Pharma Pulse: Alkermes Acquires Avadel in $2.1B Deal, BioNTech Moves to Buy CureVac, and MedTech Industry Embraces Digital-First Models
3
BioNTech Launches Public Exchange Offer for CureVac in $1.25B All-Stock Deal
4
Direct-to-patient: pharma’s next power move
5
